Table 4.
Comparison of the five alternative antibiotics with the standard regimens as reported by Miftahussurur et al18
| Island | n | Resistant regimens (%)
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAM | AMX | MNZ | TCN | LVX | FUR | SIT | GAR | RFX | RIF | ||
|
| |||||||||||
| Total | 76 | 7 (9.1) | 4 (5.2) | 36 (46.7) | 2 (2.6) | 24 (31.2) | 0 (0.0) | 0 (0.0) | 5 (6.5) | 27 (35.5) | 0 (0.0) |
| Bali | 6 | 1 (16.7) | 0 (0.0) | 2 (33.3) | 0 (0.0) | 1 (16.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (50.0) | 0 (0.0) |
| Java | 13 | 3 (23.0) | 0 (0.0) | 7 (46.1) | 2 (15.4) | 7 (53.8) | 0 (0.0) | 0 (0.0) | 2 (15.4) | 4 (30.7) | 0 (0.0) |
| Kalimantan | 5 | 0 (0.0) | 0 (0.0) | 1 (20.0) | 0 (0.0) | 1 (20.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (60.0) | 0 (0.0) |
| Papua | 7 | 1 (14.3) | 1 (14.3) | 3 (42.9) | 0 (0.0) | 2 (28.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (28.5) | 0 (0.0) |
| Sulawesi | 13 | 1 (7.7) | 1 (7.7) | 4 (30.8) | 0 (0.0) | 2 (15.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 6 (46.1) | 0 (0.0) |
| Sumatera | 18 | 1 (5.6) | 1 (5.6) | 16 (88.9) | 0 (0.0) | 8 (44.4) | 0 (0.0) | 0 (0.0) | 3 (16.7) | 3 (16.7) | 0 (0.0) |
| Timor | 14 | 0 (0.0) | 1 (7.1) | 3 (21.4) | 0 (0.0) | 3 (21.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 6 (42.8) | 0 (0.0) |
Abbreviations: AMX, amoxicillin; CAM, clarithromycin; FUR, furazolidone; GAR, garenoxacin; LVX, levofloxacin; MNZ, metronidazole; RFX, rifaximin; RIF, rifabutin; SIT, sitafloxacin; TCN, tetracycline.